Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Sun Pharma Advanced Research Company Limited
ClinicalTrials.gov Identifier:
NCT02136927
First received: May 9, 2014
Last updated: March 8, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2016
  Estimated Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)